ConductScience.org, home

Paper7199409

Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.

Carlsen JE and 4 others. Clin Physiol, 1981. Cited by 62 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man. Papers, record 7199409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7199409

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
PubMed
Journal
Clin Physiol
PubMed
Year
1981
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
2.95
iCite
Revised in PubMed
2019-09-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carlsen JEJ E
2Kardel TT
3Hilden TT
4Tangø MM
5Trap-Jensen JJ

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GuanidinesMajor topic
HemodynamicsMajor topic
HypertensionMajor topic
PyridinesMajor topic
Vasodilator AgentsMajor topic
Adult
Blood Pressure
Cardiac Output
Female
Heart Rate
Humans
Hydralazine
Male
Middle Aged
Pinacidil
Stroke Volume
Vascular Resistance

Source PubMed

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
10,821,782Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat.Br J Pharmacol2000https://conductscience.org/library/papers/10821782PubMed
6,653,652Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6653652PubMed
6,626,426Preliminary evaluation of pinacidil in hypertension.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6626426PubMed
6,487,460Pinacidil monotherapy for hypertension.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487460PubMed
6,468,476Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6468476PubMed
4,041,331The effects of long-acting pinacidil on intra-arterial blood pressure.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4041331PubMed
4,029,244Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4029244PubMed
4,029,243Long-term effects of pinacidil in hypertensive dialysis patients.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4029243PubMed
4,007,040Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4007040PubMed
3,978,025Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3978025PubMed
3,803,413Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3803413PubMed
3,768,241Acute haemodynamic effects of pinacidil in man.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3768241PubMed
3,254,831Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension.Drugs1988https://conductscience.org/library/papers/3254831PubMed
3,254,830Vasodilatation with pinacidil. Mode of action in rat resistance vessels.Drugs1988https://conductscience.org/library/papers/3254830PubMed
3,219,470Pinacidil opens K+-selective channels causing hyperpolarization and relaxation of noradrenaline contractions in rat mesenteric resistance vessels.Br J Pharmacol1988https://conductscience.org/library/papers/3219470PubMed
3,111,575Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate.Br J Pharmacol1987https://conductscience.org/library/papers/3111575PubMed
3,076,136Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.Drugs1988https://conductscience.org/library/papers/3076136PubMed
2,876,898Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/2876898PubMed
2,848,206The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/2848206PubMed
2,676,058Effects of pinacidil on the sympatho-adrenal system in dogs.Br J Pharmacol1989https://conductscience.org/library/papers/2676058PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7199409

GET https://conductscience.org/api/papers/v1/7199409/cited_by?page=2